STOCKHOLM, Sweden, Sept. 13, 2005 (PRIMEZONE) -- INVITATION:
ASTRO, the American Society for Therapeutic Radiology and Oncology will be holding its annual meeting this year at the Pepsi Center in Denver, Colorado, October 16-20, 2005. ASTRO is the most important clinical meeting and trade show for radiation oncology. Investors, who want to get a deeper knowledge about the radiation oncology business and the competitive situation, are recommended to visit this event. More information on www.astro.org.
Elekta will host a Capital Markets Day on Monday, October 17, 2.00pm -- approx. 4.30pm at the Adam's Mark Hotel in downtown Denver. Presentations will be held on the current events and future prospects of the Elekta Group, especially in light of the acquisition in April this year of IMPAC Medical Systems. Inc. Presenters will be:
- Tomas Puusepp, President and CEO of Elekta
- Joseph K. Jachinowski, one of IMPAC's founders and recently appointed Executive Vice President Product Creation at Elekta
- Anthony G. DeCarolis, CEO of Elekta Inc. and head of Elekta's operations in North America
- Dee Mathieson, Vice President Product Management
Investors who want to attend the Capital Markets Day are kindly requested to give notice by e-mail to ir@elekta.com.
For further information, please contact:
United States: Lars Jonsteg, VP Investor Relations North America, Elekta, USA Phone: +46 708 78 37 35, e-mail: lars.jonsteg@elekta.com
International: Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ), Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.com
About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife(R) for non-invasive treatment of brain surgery and Elekta Synergy(R) for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, The Elekta Group is the world's largest supplier of oncology software.
Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 1700 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb.
This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=130009&fn=wkr0001.pdf PDF version